Moexipril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor primarily used in the management of hypertension and congestive heart failure by blocking the conversion of angiotensin I to… Read more



Moexipril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor primarily used in the management of hypertension and congestive heart failure by blocking the conversion of angiotensin I to angiotensin II. This category provides access to high-quality reference standards essential for comprehensive analytical testing and method validation within pharmaceutical research. The collection includes the active pharmaceutical ingredient alongside its related compounds, such as pharmacopeial and non-pharmacopeial impurities like diketopiperazines, active metabolites including moexiprilat and its glucuronide derivatives, and stable isotope-labelled compounds. These materials are critical for accurate impurity profiling and precise quantitative analysis during quality control procedures, ensuring rigorous compliance with regulatory standards throughout the drug development lifecycle.